The Rosuvastatin Calcium market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.
In China market, the top players include
- AstraZeneca
- Teva Pharmaceutical Industries
- MSN Laboratories
- Cadila Pharmaceuticals
- LGM Pharma
- Bal Pharma
- Changzhou Pharmaceutical Factory
- Jingxin Pharm
- Zhejiang Hisun Pharmaceutical
- HEC Pharm
- Lunan Pharmaceutical
- Nanjing Frochem Tech
- Lianyungang Runzhong Pharmaceutical
- Shandong Bechem Chemicals
- CTX Life Sciences
This report with sales, revenue and market share for each type, split by product types/category, covering
- Purity 98.0%
- Purity 99.0%
- Other
This report focuses on sales, market share and growth rate of Rosuvastatin Calcium in each application, split by applications/end use industries, covers
Tablet (including dispersible tablet and general tablet)